Raymond Magorien is a Cardiology physician affiliated with The Ohio State University. OpenAlex indexes 87 publications with 4,918 citations (h-index 33).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
452 W 10th Ave
Columbus, OH 432101240
Telephone
614-293-7677Provider last certified this registry record 20 Apr 2026.
Industry payments
2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Shockwave Medical, IncProgram year20221 payment
- Inari Medical, Inc.Program year20211 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
84.8%Beta blocker22.6%Carvedilol41%Metoprolol Succinate39%Metoprolol Tartrate20%Part D≥42 patientsStatin17.2%Atorvastatin Calcium52%Rosuvastatin Calcium48%Part D≥42 patients+ 9 more classes in this area
Blood & clotting
11.3%Factor Xa inhibitor5.3%Eliquis79%Xarelto21%Part D<11 patientsP2Y12 inhibitor4.5%Clopidogrel100%Part D≥23 patients+ 1 more class in this area
Metabolism & gastrointestinal
3.9%Potassium supplement3.9%Potassium Chloride79%Klor-Con M2021%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
2 NIH research awards on record, funded 1987–2008 per NIH RePORTER. The latest:
- CLINICAL TRIAL: TRIAL TO ASSESS CHELATION THERAPY (TACT)
Ohio State University
FY2008$22,174M01RR000034
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Clinical and Angiographic Outcomes After Treatment of De Novo Coronary Stenoses With a Novel Platinum Chromium Thin-Strut Stent
Journal of the American College of Cardiology
2010
Similar KOLs
Other experts from the same institution or the same specialty.
Ernest Mazzaferri, MD
The Ohio State University
Jennifer Woyach, MD
The Ohio State University
Steven Gabbe, MD
The Ohio State University
Carl Leier, MD
The Ohio State University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”